The Community Guide

- gsearch

Search Results

Narrow Results:

2021 2
2019 2
2001 1

Université Laval. 1

United States 2

Journal Article 4
Presentation 1

Conference Publications 1

1 - 5 of 5 Results

Refine Results

Refine Results:

Estimated prevalence and incidence of disease-associated HPV types among 15–59-year-olds in the United States

CITE Title : Estimated prevalence and incidence of disease-associated HPV types among 15–59-year-olds in the United States Personal Author(s) : Lewis, Rayleen M.;Laprise, Jean-François;Gargano, Julia W.;Unger, Elizabeth R.;Querec, Troy D.;Chesson, Harrell;Brisson, Marc;Markowitz, Lauri E.; Published Date : 4 01 2021 Source : Sex Transm Dis. 48(4):273-277 URL : https://stacks.cdc.gov/view/cdc/126193 Lewis, Rayleen M. et al. (2021). Estimated prevalence and incidence of disease-associated HPV types among 15–59-year-olds in the United States. 48(4). Lewis, Rayleen M. et al. "Estimated prevalence and incidence of disease-associated HPV types among 15–59-year-olds in the United States" 48, no. 4 (2021) Lewis, Rayleen M. et al. "Estimated prevalence and incidence of disease-associated HPV types among 15–59-year-olds in the United States" vol. 48, no. 4, 2021 Export RIS Citation Information.

:

Lewis, Rayleen M. ;

Laprise, Jean-François

4 01 2021 | Sex Transm Dis. 48(4):273-277

:

Introduction:Human papillomavirus (HPV) can cause anogenital warts and several types of cancer, including cervical cancers and precancers. We estimate...
The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018

CITE Title : The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018 Personal Author(s) : Chesson, Harrell W.;Spicknall, Ian H.;Bingham, Adrienna;Brisson, Marc;Eppink, Samuel T.;Farnham, Paul G.;Kreisel, Kristen M.;Kumar, Sagar;Laprise, Jean-François;Peterman, Thomas A.;Roberts, Henry;Gift, Thomas L.; Published Date : 4 01 2021;4-01-; Source : Sex Transm Dis. 48(4):215-221 URL : https://stacks.cdc.gov/view/cdc/135964 Chesson, Harrell W. et al. (2021). The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018. 48(4). Chesson, Harrell W. et al. "The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018" 48, no. 4 (2021) Chesson, Harrell W. et al. "The Estimated Direct Lifetime Medical Costs of Sexually Transmitted Infections Acquired in the United States in 2018" vol. 48, no. 4, 2021 Export RIS Citation Information.

:

Chesson, Harrell W. ;

Spicknall, Ian H.

4 01 2021 | Sex Transm Dis. 48(4):215-221

:

Background:We estimated the lifetime medical costs attributable to STIs acquired in 2018, including sexually acquired HIV.Methods:We estimated the lif...
The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018

CITE Title : The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018 Personal Author(s) : Chesson, Harrell W.;Laprise, Jean-François;Brisson, Marc;Martin, Dave;Ekwueme, Donatus U.;Markowitz, Lauri E.; Published Date : 4-01- Source : Sex Transm Dis. 48(4):278-284 URL : https://stacks.cdc.gov/view/cdc/125200 Chesson, Harrell W. et al. (2001). The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018. 48(4). Chesson, Harrell W. et al. "The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018" 48, no. 4 (2001) Chesson, Harrell W. et al. "The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018" vol. 48, no. 4, 2001 Export RIS Citation Information.

:

Chesson, Harrell W. ;

Laprise, Jean-François

4-01- | Sex Transm Dis. 48(4):278-284

:

Introduction:We estimated the lifetime medical costs of diagnosed cases of diseases attributable to human papillomavirus (HPV) infections acquired in ...
Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States

CITE Title : Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States Personal Author(s) : Laprise, Jean-François;Chesson, Harrell W.;Markowitz, Lauri E.;Drolet, Mélanie;Martin, Dave;Bénard, Élodie;Brisson, Marc; Published Date : December 10 2019 Source : Ann Intern Med. 172(1):22-29 URL : https://stacks.cdc.gov/view/cdc/88008 Laprise, Jean-François et al. (2019). Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States. 172(1). Laprise, Jean-François et al. "Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States" 172, no. 1 (2019) Laprise, Jean-François et al. "Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United States" vol. 172, no. 1, 2019 Export RIS Citation Information.

:

Laprise, Jean-François ;

Chesson, Harrell W.

December 10 2019 | Ann Intern Med. 172(1):22-29

:

Background:In the United States, the routine age for human papillomavirus (HPV) vaccination is 11 to 12 years, with catch-up vaccination through age 2...
Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S.

CITE Title : Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S. Personal Author(s) : Brisson, Marc;Laprise, Jean-François; Corporate Authors(s) : Université Laval. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2019 February 27-28 : Atlanta, GA) Published Date : February 27, 2019 Series : ACIP meeting Human Papillomavirus (HPV) Vaccines Update URL : https://stacks.cdc.gov/view/cdc/78081 Brisson, Marc and Laprise, Jean-François (2019). Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S.. 201901(010403). Brisson, Marc and Laprise, Jean-François "Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S." 201901, no. 010403 (2019) Brisson, Marc and Laprise, Jean-François "Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S." vol. 201901, no. 010403, 2019 Export RIS Citation Information.

:

Brisson, Marc ;

Laprise, Jean-François

February 27, 2019 | ACIP meeting Human Papillomavirus (HPV) Vaccines Update

:

HPV-3-Brisson-508.pdf